BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8885832)

  • 1. Flavin reductase P: structure of a dimeric enzyme that reduces flavin.
    Tanner JJ; Lei B; Tu SC; Krause KL
    Biochemistry; 1996 Oct; 35(42):13531-9. PubMed ID: 8885832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the control of luminescence in Beneckea harveyi: properties of the NADH and NADPH:FMN oxidoreductases.
    Jablonski E; DeLuca M
    Biochemistry; 1978 Feb; 17(4):672-8. PubMed ID: 23827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity purification of bacterial luciferase and NAD(P)H:FMN oxidoreductases by FMN-sepharose for analytical applications.
    Lavi JT; Raunio RP; Stahlberg TH
    J Biolumin Chemilumin; 1990; 5(3):187-92. PubMed ID: 2220416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a second form of NADPH-flavin reductase purified from human erythrocytes.
    Yubisui T; Tamura M; Takeshita M
    Biochem Int; 1987 Jul; 15(1):1-8. PubMed ID: 3453680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavin mononucleotide reductase of luminous bacteria.
    Duane W; Hastings JW
    Mol Cell Biochem; 1975 Jan; 6(1):53-64. PubMed ID: 47604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 31P-nuclear-magnetic-resonance study of NADPH-cytochrome-P-450 reductase and of the Azotobacter flavodoxin/ferredoxin-NADP+ reductase complex.
    Bonants PJ; Müller F; Vervoort J; Edmondson DE
    Eur J Biochem; 1990 Jul; 190(3):531-7. PubMed ID: 2115440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NADPH-cytochrome P-450 reductase. Physical properties and redox behavior in the absence of the FAD moiety.
    Kurzban GP; Howarth J; Palmer G; Strobel HW
    J Biol Chem; 1990 Jul; 265(21):12272-9. PubMed ID: 2115516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Evidence for specific NADH- and NADPH-FMN reductases in bacterial bioluminescence.
    Charlier J; Gerlo E
    Arch Int Physiol Biochim; 1975 May; 83(2):354-6. PubMed ID: 54079
    [No Abstract]   [Full Text] [Related]  

  • 9. MSMEG_3955 from Mycobacterium smegmatis is a FMN bounded homotrimeric NAD(P)H:Flavin mononucleotide (FMN) oxidoreductase.
    Khosla N; Thayil SM; Kaur R; Kesavan AK
    BMC Microbiol; 2021 Nov; 21(1):319. PubMed ID: 34798816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NADPH-cytochrome P-450 oxidoreductase: flavin mononucleotide and flavin adenine dinucleotide domains evolved from different flavoproteins.
    Porter TD; Kasper CB
    Biochemistry; 1986 Apr; 25(7):1682-7. PubMed ID: 3085707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis.
    Shen AL; Porter TD; Wilson TE; Kasper CB
    J Biol Chem; 1989 May; 264(13):7584-9. PubMed ID: 2708380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and properties of the NADH and NADPH specific FMN oxidoreductases from Beneckea harveyi.
    Jablonski E; DeLuca M
    Biochemistry; 1977 Jun; 16(13):2932-6. PubMed ID: 880288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplified luminometric assays of alkaline phosphatase using riboflavin phosphates.
    Harbron S; Eggelte HJ; Benson SM; Rabin BR
    J Biolumin Chemilumin; 1991; 6(4):251-8. PubMed ID: 1665279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of NADH-specific and NADPH-specific FMN reductases in Beneckea harveyi.
    Gerlo E; Charlier J
    Eur J Biochem; 1975 Sep; 57(2):461-7. PubMed ID: 1175652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luminescence and respiratory activities of Photobacterium phosphoreum. Competition for cellular reducing power.
    Watanabe H; Mimura N; Takimoto A; Nakamura T
    J Biochem; 1975 Jun; 77(6):1147-55. PubMed ID: 5397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of a cytochrome P450-redox partner electron-transfer complex.
    Sevrioukova IF; Li H; Zhang H; Peterson JA; Poulos TL
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1863-8. PubMed ID: 10051560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation of bacterial luminescence reaction inhibitor from Photobacterium sp. cells].
    Kratasiuk GA; Kratasiuk VA; Shenderov AN; Fish AM
    Biokhimiia; 1978 Aug; 43(8):1369-76. PubMed ID: 737225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the bacterial luciferase/flavin complex provides insight into the function of the beta subunit.
    Campbell ZT; Weichsel A; Montfort WR; Baldwin TO
    Biochemistry; 2009 Jul; 48(26):6085-94. PubMed ID: 19435287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extreme pKa displacements at the active sites of FMN-dependent alpha-hydroxy acid-oxidizing enzymes.
    Lederer F
    Protein Sci; 1992 Apr; 1(4):540-8. PubMed ID: 1338973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron release from ferrisiderophores. A multi-step mechanism involving a NADH/FMN oxidoreductase and a chemical reduction by FMNH2.
    Hallé F; Meyer JM
    Eur J Biochem; 1992 Oct; 209(2):621-7. PubMed ID: 1425668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.